Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Adi Mor, PhD$16.9M
Market Cap • 25/07/20242011
(há 13 anos)
2021
(3 years ago)
NASDAQ
Listagem
Tel Aviv
37
N° de Empregados • 2022Retorno Histórico
CMMBSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.